ChromaCode Inc, a molecular diagnostics company, has secured $28 million in Series C financing. Northpond Ventures. In addition to the funding, Pat Smerkers of Northpond has joined ChromaCode’s board of directors.
Source: Press Release
Molecular diagnostics firm ChromaCode nets $28 mln Series C
ChromaCode Inc, a molecular diagnostics company, has secured $28 million in Series C financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: